Skip to content
Open access

Multi-omics screening and functional validation identify SLC5A6 as a candidate disulfidptosis-related gene and prognostic biomarker in hepatocellular carcinoma

Aug 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 29 references
Medicine

TL;DR

The findings suggest that SLC5A6 may participate in glucose-deprivation-induced disulfide stress, while its direct role in regulating disulfidptotic cell death remains to be established.

Abstract

Objective Hepatocellular carcinoma (HCC) is characterized by frequent recurrence, therapeutic resistance, and marked metabolic adaptability. Disulfidptosis is a recently described form of regulated cell death associated with glucose deprivation and disulfide stress. This study aimed to identify disulfidptosis-related genes associated with HCC progression and to investigate the potential biological role of SLC5A6. Methods Single-cell RNA sequencing and TCGA-LIHC transcriptomic data were integrated. A literature-derived, non-directional disulfidptosis-related gene-set enrichment score was calculated using ssGSEA, and copy-number alterations were inferred using inferCNV. WGCNA, differential expression analysis, and the SLC-family gene list were integrated to identify candidate genes. Bayesian deconvolution, ESTIMATE, TIDE, and GSVA were used to evaluate tumor-microenvironment-related features and pathway signatures. The biological effects of SLC5A6 silencing were assessed using proliferation, migration, invasion, apoptosis, and xenograft assays. Glucose-deprivation-induced disulfide stress was further evaluated by measuring protein disulfide content, the NADP+/NADPH ratio, and FLNA and FLNB band patterns under non-reducing conditions. Results Single-cell analysis showed that malignant hepatocytes with higher inferCNV-derived CNV scores exhibited greater enrichment of the disulfidptosis-related gene signature. Integration of glucose-deprivation-associated DEGs, WGCNA modules, and SLC-family genes identified SLC5A6 as a candidate disulfidptosis-related gene that was upregulated in HCC and associated with poor prognosis. Bayesian deconvolution, ESTIMATE, TIDE, and GSVA analyses linked elevated SLC5A6 expression to advanced disease, stromal and immunosuppressive cell enrichment, higher T-cell exclusion scores, and activation of Wnt/mTOR-related signaling signatures. In SLC7A11-high HCC cells, glucose deprivation increased protein disulfide content and the NADP+/NADPH ratio and altered non-reducing FLNA and FLNB band patterns, whereas these changes were partially attenuated by SLC5A6 silencing. Under conventional culture conditions, SLC5A6 silencing inhibited proliferation, migration, invasion, and xenograft growth and increased apoptosis. Conclusion SLC5A6 is a candidate disulfidptosis-related gene and prognostic biomarker associated with malignant progression in HCC. The findings suggest that SLC5A6 may participate in glucose-deprivation-induced disulfide stress, while its direct role in regulating disulfidptotic cell death remains to be established. Its associations with immune-exclusion-related features also require further functional validation.

Read PDF

Similar papers

Aug 2026

Identification of GOT1, OAF, XPNPEP2, CRISPLD2, and RPS21 as Sorafenib-Treatment-Associated Candidate Biomarkers for Hepatocellular Carcinoma.

This study identified candidate biomarkers related to sorafenib treatment for HCC through computational analyses, experimentally validated the oncogenic function of RPS21, and predicted carbamazepine and diclofenac as potential combination therapies for precision treatment of HCC.

Mengru Zhan, Peng-Hui Li, Wan-Yi Wang et al. · 0 citations
Open access Jul 2026

A TMED3-governed disulfidptosis-related diagnostic signature reveals tumor microenvironment remodeling in intrahepatic cholangiocarcinoma

This study provides a comprehensive single−cell atlas of ICC, identifies TMED3 as a key regulator of a disulfidptosis−related diagnostic signature, and demonstrates its functional role in promoting ICC malignancy.

Wan-Jia Qiao, Yixiang He, Jing Li et al. · 0 citations
Open access Sep 2026

Multi-omics characterization of anoikis-related hub genes and macrophage-centered immune persistence with validation of HAVCR2 in atherosclerosis

A macrophage-centered anoikis-related immune signature in atherosclerosis is defined and HAVCR2 is identified, together with CD36, PLAU, TNF, PYCARD, SERPINA1, BLNK, and CHI3L1, as potential biomarkers and candidate targets for future diagnostic and therapeutic investigation.

Qiang Shen, Zheng-Feng Fan, Jin-Cheng Hou et al. · 0 citations
Jul 2026

Construction and Validation of a Ubiquitination-Related Gene Signature Based on WGCNA and Single-cell RNA Sequencing in Bladder Cancer.

The six-gene ubiquitination-related signature may provide a valuable reference for potential therapeutic targets and prognosis of BC, however, prospective and experimental validation is still required.

Zhi-Biao Li, Ting Yan, Chuxiang Hu et al. · 0 citations
Open access Aug 2026

Lipid Metabolism-related lncRNA Model Identifies AC026412.3 as a Driver of Fatty Acid β-oxidation in Hepatocellular Carcinoma

This study establishes a robust LRL-based prognostic model and identifies AC026412.3 as a key regulator of lipid metabolic reprogramming via the SLC22A5–fatty acid β-oxidation axis, highlighting its potential as a biomarker and therapeutic target in HCC.

Li-Xin Liu, Yu-Hao Fan, Hao Zou et al. · 0 citations
Open access Aug 2026

Integrative multi-omics identifies PANX2 as a ferroptosis suppressor and potential therapeutic target in clear cell renal cell carcinoma

PANX2 is identified as a ccRCC-relevant suppressor of ferroptosis and supports the involvement of a PANX2-Akt/mTOR-SLC7A11-associated signaling axis in redox homeostasis and tumor progression.

Xing-Lin Li, Yiqi Xiong, Ji-Yin Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.